Gemphire Therapeutics, Inc.

/Gemphire Therapeutics, Inc.

They are a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH.

Symbol

Last Closing Price
$8.63

Shares
2,860,000

Effective Date
February 8, 2018

Underwriters

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange